Mission Street and BGO announce Orbit Discovery as the latest occupier at Inventa

As we close out the year, it’s wonderful to be able to announce Orbit Discovery as the latest occupier taking occupation at Inventa.

Orbit Discovery, which was spun out of the University of Oxford in 2016 and provides peptide discovery services for therapeutic applications, has committed to a new lease of 8,300 sq ft of fitted labs and office and joins a growing roster of innovation companies in Oxford’s emerging central cluster for science and technology, including Nucleome Therapeutics, Xyme, and Oxford Semantic Technologies and Oxford Cancer Analystics.

Brett Rowley, VP of Finance at Orbit Discovery, said

“We spent a great deal of time testing the market in our search for our new premises, but we landed at Inventa for a variety of reasons. We were particularly drawn by the building’s central location, the unique building design and the quality of the space both in common areas and within our premises.  We look forward to moving into our modern labs and office space early in the new year.”